NCT06512064 Acoustic Waveform Respiratory Evaluation
| NCT ID | NCT06512064 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Indiana University |
| Condition | Asthma |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2024-07-23 |
| Primary Completion | 2029-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2024-07-23 with a primary completion date of 2029-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study will evaluate the feasibility of using smartphone speakers and microphones to evaluate the caliber of the airways, detect airway obstruction, aid in airway disease diagnosis, and identify disease exacerbations.
Eligibility Criteria
Inclusion Criteria: 1. Age 8-70 years 2. Ability to perform spirometry and oscillometry 3. Signed informed consent (and assent for children as appropriate) 4. No respiratory or other major disease (for healthy controls), or physician-diagnosed asthma, COPD, CF, or other airway diseases Exclusion Criteria: 1. Inability or unwillingness to perform AWARE, spirometry, or oscillometry 2. Acute or chronic illness that, at the judgement of investigators, may affect lung function and alter the results of AWARE or the reference PFTs (spirometry and AOS)
Contact & Investigator
Erick Forno, MD MPH
PRINCIPAL INVESTIGATOR
Indiana University
Frequently Asked Questions
Who can join the NCT06512064 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 70 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06512064 currently recruiting?
Yes, NCT06512064 is actively recruiting participants. Contact the research team at lizbuell@iu.edu for enrollment information.
Where is the NCT06512064 trial being conducted?
This trial is being conducted at Indianapolis, United States, Pittsburgh, United States.
Who is sponsoring the NCT06512064 clinical trial?
NCT06512064 is sponsored by Indiana University. The principal investigator is Erick Forno, MD MPH at Indiana University. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.